Arena Pharmaceuticals, Inc.

Press Releases



All Releases

View Summary Arena Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update
Nov 10, 2015
PDF 22.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Third Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, November 10
Nov 4, 2015
PDF 12.3 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at 2015 Annual Obesity Week Meeting
Nov 2, 2015
PDF 21.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Initiates a Phase 1b Clinical Trial of APD371
Oct 29, 2015
PDF 11.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces New Strategic Focus and Cost Reduction Plan
Oct 27, 2015
PDF 13.3 KB Add to Briefcase
View Summary Arena Pharmaceuticals Issued Additional Patent Covering BELVIQ® (lorcaserin HCl) by United States Patent and Trademark Office
Oct 27, 2015
PDF 20.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Retirement of President and CEO
Oct 5, 2015
PDF 12.0 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at Upcoming Medical Meetings
Sep 24, 2015
PDF 19.3 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Wells Fargo 2015 Healthcare Conference
Sep 3, 2015
PDF 11.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update
Aug 5, 2015
PDF 23.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5
Jul 30, 2015
PDF 12.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Initiates a Phase 2 Clinical Trial of APD334, its S1P1 Receptor Modulator for Autoimmune Diseases
Jul 29, 2015
PDF 13.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces the Departure of Chief Financial Officer
Jun 16, 2015
PDF 11.9 KB Add to Briefcase
View Summary Lorcaserin HCl Data to be Presented at American Diabetes Association's 75th Scientific Sessions
Jun 4, 2015
PDF 19.3 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference
May 26, 2015
PDF 11.3 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at Upcoming Medical Meetings
May 14, 2015
PDF 19.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2015 Financial Results
May 11, 2015
PDF 24.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals and Roivant Sciences Enter into Collaboration for Nelotanserin, a Novel Inverse Agonist of the 5-HT2A Receptor
May 11, 2015
PDF 13.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference
May 8, 2015
PDF 11.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host First Quarter 2015 Financial Results Conference Call and Webcast on Monday, May 11
May 7, 2015
PDF 12.1 KB Add to Briefcase
Showing 21-40 of 525 Page: 1 2 3 4 5 6 ... 27  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase